BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tyagi AK, Agarwal C, Singh RP, Shroyer KR, Glode LM, Agarwal R. Silibinin down-regulates survivin protein and mRNA expression and causes caspases activation and apoptosis in human bladder transitional-cell papilloma RT4 cells. Biochem Biophys Res Commun. 2003;312:1178-1184. [PMID: 14651997 DOI: 10.1016/j.bbrc.2003.11.038] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Mashhadi Akbar Boojar M, Mashhadi Akbar Boojar M, Golmohammad S. Overview of Silibinin anti-tumor effects. Journal of Herbal Medicine 2020;23:100375. [DOI: 10.1016/j.hermed.2020.100375] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
2 Ko JW, Shin NR, Park SH, Lee IC, Ryu JM, Kim HJ, Cho YK, Kim JC, Shin IS. Silibinin inhibits the fibrotic responses induced by cigarette smoke via suppression of TGF-β1/Smad 2/3 signaling. Food Chem Toxicol 2017;106:424-9. [PMID: 28602599 DOI: 10.1016/j.fct.2017.06.016] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
3 Deep G, Agarwal R. Chemopreventive Efficacy of Silymarin in Skin and Prostate Cancer. Integr Cancer Ther 2007;6:130-45. [DOI: 10.1177/1534735407301441] [Cited by in Crossref: 80] [Cited by in F6Publishing: 65] [Article Influence: 13.3] [Reference Citation Analysis]
4 Zhu XX, Ding YH, Wu Y, Qian LY, Zou H, He Q. Silibinin: a potential old drug for cancer therapy. Expert Rev Clin Pharmacol. 2016; 18: 1-8 Epub ahead of print. [PMID: 27362364 DOI: 10.1080/17512433.2016.1208563] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 3.5] [Reference Citation Analysis]
5 Viau CM, Moura DJ, Pflüger P, Facundo VA, Saffi J. Structural Aspects of Antioxidant and Genotoxic Activities of Two Flavonoids Obtained from Ethanolic Extract of Combretum leprosum. Evid Based Complement Alternat Med 2016;2016:9849134. [PMID: 27478483 DOI: 10.1155/2016/9849134] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
6 Farooqi AA, Wu SJ, Chang YT, Tang JY, Li KT, Ismail M, Liaw CC, Li RN, Chang HW. Activation and Inhibition of ATM by Phytochemicals: Awakening and Sleeping the Guardian Angel Naturally. Arch Immunol Ther Exp (Warsz) 2015;63:357-66. [PMID: 26089209 DOI: 10.1007/s00005-015-0346-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
7 Gu HR, Park SC, Choi SJ, Lee JC, Kim YC, Han CJ, Kim J, Yang KY, Kim YJ, Noh GY, No SH, Jeong JH. Combined treatment with silibinin and either sorafenib or gefitinib enhances their growth-inhibiting effects in hepatocellular carcinoma cells. Clin Mol Hepatol 2015;21:49-59. [PMID: 25834802 DOI: 10.3350/cmh.2015.21.1.49] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
8 Mittal A, Tabasum S, Singh RP. Berberine in combination with doxorubicin suppresses growth of murine melanoma B16F10 cells in culture and xenograft. Phytomedicine 2014;21:340-7. [PMID: 24176840 DOI: 10.1016/j.phymed.2013.09.002] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 4.1] [Reference Citation Analysis]
9 Ting H, Deep G, Agarwal R. Molecular mechanisms of silibinin-mediated cancer chemoprevention with major emphasis on prostate cancer. AAPS J 2013;15:707-16. [PMID: 23588585 DOI: 10.1208/s12248-013-9486-2] [Cited by in Crossref: 51] [Cited by in F6Publishing: 43] [Article Influence: 5.7] [Reference Citation Analysis]
10 Srigopalram S, Ilavenil S, Jayraaj IA. Apoptosis associated inhibition of DEN-induced hepatocellular carcinogenesis by ellagic acid in experimental rats. Biomedicine & Preventive Nutrition 2012;2:1-8. [DOI: 10.1016/j.bionut.2011.12.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
11 Deep G, Agarwal R. Antimetastatic efficacy of silibinin: molecular mechanisms and therapeutic potential against cancer. Cancer Metastasis Rev 2010;29:447-63. [PMID: 20714788 DOI: 10.1007/s10555-010-9237-0] [Cited by in Crossref: 149] [Cited by in F6Publishing: 129] [Article Influence: 12.4] [Reference Citation Analysis]
12 Li L, Zeng J, Gao Y, He D. Targeting silibinin in the antiproliferative pathway. Expert Opinion on Investigational Drugs 2010;19:243-55. [DOI: 10.1517/13543780903533631] [Cited by in Crossref: 43] [Cited by in F6Publishing: 33] [Article Influence: 3.6] [Reference Citation Analysis]
13 Chen Q, Cao M, Xiang WL, Sun Q, Zhang J, Hou RT, Yan ZY, Yang ZR, Liu J, Zhao J. Study on genes with altered expression in alpha-amanitin poisoned mice and evaluation on antagonistic effects of traditional Chinese medicines against toxicity of alpha-amanitin. Acta Biol Hung 2009;60:281-91. [PMID: 19700387 DOI: 10.1556/ABiol.60.2009.3.5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
14 Pereira BK, Rosa RM, Silva JD, Guecheva TN, Oliveira IMD, Ianistcki M, Benvegnú VC, Furtado GV, Ferraz A, Richter MF, Schroder N, Pereira AB, Henriques JAP. Protective effects of three extracts from Antarctic plants against ultraviolet radiation in several biological models. Journal of Photochemistry and Photobiology B: Biology 2009;96:117-29. [DOI: 10.1016/j.jphotobiol.2009.04.011] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
15 Ryan BM, O'Donovan N, Duffy MJ. Survivin: a new target for anti-cancer therapy. Cancer Treat Rev 2009;35:553-62. [PMID: 19559538 DOI: 10.1016/j.ctrv.2009.05.003] [Cited by in Crossref: 273] [Cited by in F6Publishing: 255] [Article Influence: 21.0] [Reference Citation Analysis]
16 Li L, Gao Y, Zhang L, Zeng J, He D, Sun Y. Silibinin inhibits cell growth and induces apoptosis by caspase activation, down-regulating survivin and blocking EGFR–ERK activation in renal cell carcinoma. Cancer Letters 2008;272:61-9. [DOI: 10.1016/j.canlet.2008.06.033] [Cited by in Crossref: 62] [Cited by in F6Publishing: 45] [Article Influence: 4.4] [Reference Citation Analysis]
17 Bang CI, Paik SY, Sun DI, Joo YH, Kim MS. Cell growth inhibition and down-regulation of survivin by silibinin in a laryngeal squamous cell carcinoma cell line. Ann Otol Rhinol Laryngol 2008;117:781-5. [PMID: 18998509 DOI: 10.1177/000348940811701014] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
18 Chittezhath M, Deep G, Singh RP, Agarwal C, Agarwal R. Silibinin inhibits cytokine-induced signaling cascades and down-regulates inducible nitric oxide synthase in human lung carcinoma A549 cells. Mol Cancer Ther 2008;7:1817-26. [PMID: 18644994 DOI: 10.1158/1535-7163.MCT-08-0256] [Cited by in Crossref: 53] [Cited by in F6Publishing: 26] [Article Influence: 3.8] [Reference Citation Analysis]
19 Deep G, Oberlies NH, Kroll DJ, Agarwal R. Identifying the differential effects of silymarin constituents on cell growth and cell cycle regulatory molecules in human prostate cancer cells. Int J Cancer 2008;123:41-50. [PMID: 18435416 DOI: 10.1002/ijc.23485] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 3.3] [Reference Citation Analysis]
20 Parry JW, Cheng Z, Moore J, Yu LL. Fatty Acid Composition, Antioxidant Properties, and Antiproliferative Capacity of Selected Cold-Pressed Seed Flours. J Am Oil Chem Soc 2008;85:457-64. [DOI: 10.1007/s11746-008-1207-0] [Cited by in Crossref: 29] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
21 Abe S, Hasegawa M, Yamamoto K, Kurata M, Nakagawa Y, Suzuki K, Takizawa T, Kitagawa M. Rapid induction of IAP family proteins and Smac/DIABLO expression after proapoptotic stimulation with doxorubicin in RPMI 8226 multiple myeloma cells. Experimental and Molecular Pathology 2007;83:405-12. [DOI: 10.1016/j.yexmp.2007.04.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
22 Lah JJ, Cui W, Hu KQ. Effects and mechanisms of silibinin on human hepatoma cell lines. World J Gastroenterol 2007; 13(40): 5299-5305 [PMID: 17879397 DOI: 10.3748/wjg.v13.i40.5299] [Cited by in CrossRef: 65] [Cited by in F6Publishing: 60] [Article Influence: 4.3] [Reference Citation Analysis]
23 Flaig TW, Su LJ, Harrison G, Agarwal R, Glodé LM. Silibinin synergizes with mitoxantrone to inhibit cell growth and induce apoptosis in human prostate cancer cells. Int J Cancer 2007;120:2028-33. [PMID: 17230508 DOI: 10.1002/ijc.22465] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 2.3] [Reference Citation Analysis]
24 Deep G, Oberlies NH, Kroll DJ, Agarwal R. Isosilybin B and isosilybin A inhibit growth, induce G1 arrest and cause apoptosis in human prostate cancer LNCaP and 22Rv1 cells. Carcinogenesis. 2007;28:1533-1542. [PMID: 17389612 DOI: 10.1093/carcin/bgm069] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 2.9] [Reference Citation Analysis]
25 Lee JS, Kim SG, Kim HK, Lee TH, Jeong YI, Lee CM, Yoon MS, Na YJ, Suh DS, Park NC, Choi IH, Kim GY, Choi YH, Chung HY, Park YM. Silibinin polarizes Th1/Th2 immune responses through the inhibition of immunostimulatory function of dendritic cells. J Cell Physiol 2007;210:385-97. [PMID: 17058260 DOI: 10.1002/jcp.20852] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 2.5] [Reference Citation Analysis]
26 Riles WL, Erickson J, Nayyar S, Atten MJ, Attar BM, Holian O. Resveratrol engages selective apoptotic signals in gastric adenocarcinoma cells. World J Gastroenterol 2006; 12(35): 5628-5634 [PMID: 17007014 DOI: 10.3748/wjg.v12.i35.5628] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
27 McCarty MF, Block KI. Multifocal angiostatic therapy: an update. Integr Cancer Ther 2005;4:301-14. [PMID: 16282507 DOI: 10.1177/1534735405282475] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
28 Chang JW, Kim CS, Kim SB, Park SK, Park JS, Lee SK. Proinflammatory cytokine-induced NF-kappaB activation in human mesangial cells is mediated through intracellular calcium but not ROS: effects of silymarin. Nephron Exp Nephrol 2006;103:e156-65. [PMID: 16636588 DOI: 10.1159/000092906] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
29 Jiang Y, de Bruin A, Caldas H, Fangusaro J, Hayes J, Conway EM, Robinson ML, Altura RA. Essential role for survivin in early brain development. J Neurosci. 2005;25:6962-6970. [PMID: 16049172 DOI: 10.1523/jneurosci.1446-05.2005] [Cited by in Crossref: 84] [Cited by in F6Publishing: 54] [Article Influence: 5.3] [Reference Citation Analysis]
30 Singh RP, Agarwal R. Mechanisms and preclinical efficacy of silibinin in preventing skin cancer. Eur J Cancer 2005;41:1969-79. [PMID: 16084079 DOI: 10.1016/j.ejca.2005.03.033] [Cited by in Crossref: 97] [Cited by in F6Publishing: 89] [Article Influence: 5.7] [Reference Citation Analysis]
31 Yang SH, Lin JK, Huang CJ, Chen WS, Li SY, Chiu JH. Silibinin inhibits angiogenesis via Flt-1, but not KDR, receptor up-regulation. J Surg Res 2005;128:140-6. [PMID: 15993897 DOI: 10.1016/j.jss.2005.04.042] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 1.7] [Reference Citation Analysis]
32 Weikert S, Christoph F, Schrader M, Krause H, Miller K, Müller M. Quantitative analysis of survivin mRNA expression in urine and tumor tissue of bladder cancer patients and its potential relevance for disease detection and prognosis. Int J Cancer 2005;116:100-4. [PMID: 15761870 DOI: 10.1002/ijc.21000] [Cited by in Crossref: 75] [Cited by in F6Publishing: 62] [Article Influence: 4.4] [Reference Citation Analysis]
33 Baratelli F, Krysan K, Heuzé-Vourc'h N, Zhu L, Escuadro B, Sharma S, Reckamp K, Dohadwala M, Dubinett SM. PGE2 confers survivin-dependent apoptosis resistance in human monocyte-derived dendritic cells. J Leukoc Biol 2005;78:555-64. [PMID: 15908458 DOI: 10.1189/jlb.1004569] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 2.1] [Reference Citation Analysis]
34 Gu M, Dhanalakshmi S, Mohan S, Singh RP, Agarwal R. Silibinin inhibits ultraviolet B radiation-induced mitogenic and survival signaling, and associated biological responses in SKH-1 mouse skin. Carcinogenesis 2005;26:1404-13. [PMID: 15831527 DOI: 10.1093/carcin/bgi096] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 2.8] [Reference Citation Analysis]
35 Mohan S, Dhanalakshmi S, Mallikarjuna GU, Singh RP, Agarwal R. Silibinin modulates UVB-induced apoptosis via mitochondrial proteins, caspases activation, and mitogen-activated protein kinase signaling in human epidermoid carcinoma A431 cells. Biochem Biophys Res Commun. 2004;320:183-189. [PMID: 15207719 DOI: 10.1016/j.bbrc.2004.05.153] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 2.0] [Reference Citation Analysis]
36 Rahimifard M, Moini-Nodeh S, Niaz K, Baeeri M, Jamalifar H, Abdollahi M. Improvement of the functionality of pancreatic Langerhans islets via reduction of bacterial contamination and apoptosis using phenolic compounds. Iran J Basic Med Sci 2018;21:920-7. [PMID: 30524692 DOI: 10.22038/IJBMS.2018.27718.6753] [Cited by in F6Publishing: 1] [Reference Citation Analysis]